Show simple item record

 
dc.contributorVall d'Hebron Barcelona Hospital Campus
dc.contributor.authorJiménez-Labaig, Pablo
dc.contributor.authorAymerich, Clàudia
dc.contributor.authorRullán, Antonio José
dc.contributor.authorCacicedo, Jon
dc.contributor.authorGonzalez-Torres, Miguel Angel
dc.contributor.authorBrana, Irene
dc.date.accessioned2024-06-13T07:56:56Z
dc.date.available2024-06-13T07:56:56Z
dc.date.issued2024-05-03
dc.identifier.citationJimenez-Labaig P, Aymerich C, Braña I, Rullan A, Cacicedo J, González-Torres MÁ, et al. A comprehensive examination of mental health in patients with head and neck cancer: Systematic review and meta-analysis. JNCI Cancer Spectr. 2024 May 3;8(3):pkae031.
dc.identifier.issn2515-5091
dc.identifier.urihttps://hdl.handle.net/11351/11580
dc.descriptionMental health; Head and neck cancer
dc.description.abstractBackground Patients with head and neck cancer present particularly considerable levels of emotional distress. However, the actual rates of clinically relevant mental health symptoms and disorders among this population remain unknown. Methods A Preferred Reporting Items for Systematic Review and Meta-Analyses and Meta-analyses of Observational Studies in Epidemiology–compliant systematic review and quantitative random-effects meta-analysis was performed to determine suicide incidence and the prevalence of depression, anxiety, distress, posttraumatic stress, and insomnia in this population. MEDLINE, Web of Science, Cochrane Central Register, KCI Korean Journal database, SciELO, Russian Science Citation Index, and Ovid-PsycINFO databases were searched from database inception to August 1, 2023 (PROSPERO: CRD42023441432). Subgroup analyses and meta-regressions were performed to investigate the effect of clinical, therapeutical, and methodological factors. Results A total of 208 studies (n = 654 413; median age = 60.7 years; 25.5% women) were identified. Among the patients, 19.5% reported depressive symptoms (95% confidence interval [CI] = 17% to 21%), 17.8% anxiety symptoms (95% CI = 14% to 21%), 34.3% distress (95% CI = 29% to 39%), 17.7% posttraumatic symptoms (95% CI = 6% to 41%), and 43.8% insomnia symptoms (95% CI = 35% to 52%). Diagnostic criteria assessments revealed lower prevalence of disorders: 10.3% depression (95% CI = 7% to 13%), 5.6% anxiety (95% CI = 2% to 10%), 9.6% insomnia (95% CI = 1% to 40%), and 1% posttraumatic stress (95% CI = 0% to 84.5%). Suicide pooled incidence was 161.16 per 100 000 individuals per year (95% CI = 82 to 239). Meta-regressions found a statistically significant higher prevalence of anxiety in patients undergoing primary chemoradiation compared with surgery and increased distress in smokers and advanced tumor staging. European samples exhibited lower prevalence of distress. Conclusions Patients with head and neck cancer presented notable prevalence of mental health concerns in all domains. Suicide remains a highly relevant concern. The prevalence of criteria-meeting disorders is significantly lower than clinically relevant symptoms. Investigating the effectiveness of targeted assessments for disorders in highly symptomatic patients is essential.
dc.language.isoeng
dc.publisherOxford University Press
dc.relation.ispartofseriesJNCI Cancer Spectrum;8(3)
dc.rightsAttribution 4.0 International
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.sourceScientia
dc.subjectSuïcidi
dc.subjectSalut mental
dc.subjectCap - Càncer
dc.subjectColl - Càncer
dc.subject.meshHead and Neck Neoplasms
dc.subject.meshSuicide
dc.subject.meshMental Health
dc.subject.meshPrevalence
dc.titleA comprehensive examination of mental health in patients with head and neck cancer: systematic review and meta-analysis
dc.typeinfo:eu-repo/semantics/article
dc.identifier.doi10.1093/jncics/pkae031
dc.subject.decsneoplasias de cabeza y cuello
dc.subject.decssuicidio
dc.subject.decssalud mental
dc.subject.decsprevalencia
dc.relation.publishversionhttps://doi.org/10.1093/jncics/pkae031
dc.type.versioninfo:eu-repo/semantics/publishedVersion
dc.audienceProfessionals
dc.contributor.organismesInstitut Català de la Salut
dc.contributor.authoraffiliation[Jimenez-Labaig P, Rullan A] Head and Neck Unit, The Royal Marsden NHS Foundation Trust, London, UK. The Institute of Cancer Research, National Institute of Health Research Biomedical Research Centre, London, UK. [Aymerich C] Psychiatry Department, Basurto University Hospital. Osakidetza, Basque Health Service, Bilbao, Spain. Biobizkaia Health Research Institute, OSI Bilbao-Basurto, Bilbao, Spain. Centro de Investigación en Red de Salud Mental (CIBERSAM), Madrid, Spain. [Braña I] Grup de Tumors Toràcics i Càncer de Cap i Coll, Servei d’Oncologia Mèdica, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. [Cacicedo J] Radiotherapy Department, Cruces University Hospital, Barakaldo, Spain. Biobizkaia Health Research Institute, OSI Ezkerraldea Enkarterri Cruces, Barakaldo, Spain. Faculty of Medicine, University of the Basque Country, Leioa, Spain. [González-Torres MÁ] Psychiatry Department, Basurto University Hospital. Osakidetza, Basque Health Service, Bilbao, Spain. Biobizkaia Health Research Institute, OSI Bilbao-Basurto, Bilbao, Spain. Centro de Investigación en Red de Salud Mental (CIBERSAM), Madrid, Spain. Neuroscience Department, University of the Basque Country (UPV/EHU), Leioa, Spain
dc.identifier.pmid38702757
dc.identifier.wos001238015400001
dc.rights.accessrightsinfo:eu-repo/semantics/openAccess


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record